The RelA NF-κB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells
暂无分享,去创建一个
D. W. Kim | G. Sonenshein | R. Romieu-Mourez | D. Sherr | L. Gazourian | Lee Gazourian | David H Sherr | Gail E Sonenshein | Dong W Kim | Shafat A Quadri | Raphaëlle | S. Quadri
[1] F. Matsumura,et al. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. , 1996, Biochemical pharmacology.
[2] G. Sonenshein,et al. Nuclear factor kappaB cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[3] E. Kalkhoven,et al. Distinct Domains of the RelA NF-κB Subunit Are Required for Negative Cross-talk and Direct Interaction with the Glucocorticoid Receptor* , 1997, The Journal of Biological Chemistry.
[4] T. Pineau,et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor , 1995, Science.
[5] G. Sonenshein,et al. Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[6] G. Perdew,et al. Characterization of the activated form of the aryl hydrocarbon receptor in the nucleus of HeLa cells in the absence of exogenous ligand. , 1996, Archives of biochemistry and biophysics.
[7] C. Bradfield,et al. Characterization of the Ah Receptor-associated Protein, ARA9* , 1998, The Journal of Biological Chemistry.
[8] M. Gallo,et al. Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity* , 1999, The Journal of Biological Chemistry.
[9] J. Whitlock,et al. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin , 1996, Molecular and cellular biology.
[10] R. Pollenz,et al. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. , 1994, Molecular pharmacology.
[11] K. Khalili,et al. Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1 , 1996, Journal of virology.
[12] R. Roeder,et al. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.
[13] E. Kalkhoven,et al. Negative Interaction between the RelA(p65) Subunit of NF-B and the Progesterone Receptor (*) , 1996, The Journal of Biological Chemistry.
[14] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[15] G. Held,et al. Adverse reproductive outcomes in the transgenic Ah receptor-deficient mouse. , 1999, Toxicology and applied pharmacology.
[16] D. Nebert,et al. Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin. , 1991, Pharmacogenetics.
[17] C. Elferink,et al. A Direct Interaction between the Aryl Hydrocarbon Receptor and Retinoblastoma Protein , 1998, The Journal of Biological Chemistry.
[18] G. Sonenshein,et al. NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts , 1992, The Journal of experimental medicine.
[19] A. Fornace,et al. Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm. , 1990, Environmental health perspectives.
[20] A. Bassuk,et al. Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells , 1997, Journal of virology.
[21] J. Trauger,et al. Inhibition of Ets-1 DNA Binding and Ternary Complex Formation between Ets-1, NF-κB, and DNA by a Designed DNA-binding Ligand* , 1999, The Journal of Biological Chemistry.
[22] F. A. La Rosa,et al. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors , 1994, Molecular and cellular biology.
[23] H. Swanson,et al. In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Russo,et al. Transformation of human breast epithelial cells by chemical carcinogens. , 1993, Carcinogenesis.
[25] B. Jhun,et al. Bcl3, an IκB Protein, Stimulates Activating Protein-1 Transactivation and Cellular Proliferation* , 1999, The Journal of Biological Chemistry.
[26] B. Kahn-Perlès,et al. Physical interaction of the bHLH LYL1 protein and NF-κB1 p105 , 1999, Oncogene.
[27] A. Puga,et al. Constitutive Activation of the Aromatic Hydrocarbon Receptor , 1998, Molecular and Cellular Biology.
[28] P. Harper,et al. The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. , 1994, Toxicology letters.
[29] G. Perdew,et al. Mapping the 90 kDa heat shock protein binding region of the Ah receptor , 1996, Biochemistry and molecular biology international.
[30] E M Schwarz,et al. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.
[31] P. Baeuerle,et al. The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. , 1993, The Biochemical journal.
[32] J. V. Vanden Heuvel,et al. Hepatitis B Virus X-Associated Protein 2 Is a Subunit of the Unliganded Aryl Hydrocarbon Receptor Core Complex and Exhibits Transcriptional Enhancer Activity , 1998, Molecular and Cellular Biology.
[33] E. L. Springer,et al. Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. , 1977, Journal of the National Cancer Institute.
[34] W. Greene,et al. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Stavnezer,et al. Interaction of Stat6 and NF-κB: Direct Association and Synergistic Activation of Interleukin-4-Induced Transcription , 1998, Molecular and Cellular Biology.
[36] A. Baldwin,et al. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. , 1993, Molecular and cellular biology.
[37] A. E. Rogers,et al. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.
[38] P. Toselli,et al. Induction of PreB cell apoptosis by 7,12-dimethylbenz[a]anthracene in long-term primary murine bone marrow cultures. , 1997, Toxicology and applied pharmacology.
[39] Garet P Lahvis,et al. Ahr null alleles: distinctive or different? , 1998, Biochemical pharmacology.
[40] H. Preisler,et al. Evaluation of c-myc proto-oncogene in primary human breast carcinomas. , 1991, Anticancer research.
[41] C. Bradfield,et al. Ligand-dependent Interaction of the Aryl Hydrocarbon Receptor with a Novel Immunophilin Homolog in Vivo* , 1997, The Journal of Biological Chemistry.
[42] F. A. La Rosa,et al. A novel NF-kappa B element within exon 1 of the murine c-myc gene. , 1992, Oncogene.
[43] J. Williams,et al. Characterization of 2,3,7,8-tetrachlorodibenzofuran-dependent suppression and AH receptor pathway gene expression in the developing mouse mammary gland. , 1998, Toxicology and applied pharmacology.
[44] M. Fernö,et al. c‐myc amplification is an independent prognostic factor in postmenopausal breast cancer , 1992, International journal of cancer.
[45] J. Tilly,et al. The aryl hydrocarbon receptor, a basic helix-loop-helix transcription factor of the PAS gene family, is required for normal ovarian germ cell dynamics in the mouse. , 2000, Endocrinology.